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Epidemiologic studies have shown a correla-
tion between exposure to ambient air particu-
late matter and adverse health outcomes
manifested as an increased incidence of car-
diovascular and respiratory mortality and
morbidity (Dockery et al. 1993). Diesel
exhaust particles (DEPs) are common air-
borne particulate matter that have diameters
of < 2.5 µm and contain adsorbed organic
compounds, many of which are known to
alter the pulmonary microsomal enzyme
pool, which results in altered xenobiotic
metabolism. Studies in rats have shown that
DEPs induce enhanced responses to allergic
sensitization and weaken host defenses against
bacterial infection through particulate- and/or
organic component-mediated cellular responses
(Takano et al. 2002; Yang et al. 2001; Yin
et al. 2002, 2003).
Alveolar macrophages (AMs), through
phagocytosis, release reactive oxygen species
(ROS), reactive nitrogen species, and pro-
inﬂammatory cytokines and are the principal
cell type in the lung that mediates immune/
inﬂammatory responses against inhaled parti-
cles, chemicals, and microorganisms. The gen-
eration of superoxide anion by AMs through
NADPH oxidase during the respiratory burst
is important in eliminating extracellular
pathogens (Segal 1989), whereas nitric oxide
(NO) exhibits antimicrobial activity against
pathogens that survive and proliferate in the
intracellular environment (Takano et al.
1999). In human Mycobacterium tuberculosis
infection, most tubercle bacilli reside in
macrophages and generate inducible NO syn-
thase (iNOS) expression as the cell’s major
bactericidal activity (Choi et al. 2002). The
organic content of DEPs varies with varying
sources of DEPs and is known to modulate
DEP toxicity (Singh et al. 2004). Exposure of
cells to DEP organic extracts (DEPEs) has
been shown to induce intracellular ROS gener-
ation, apoptosis (Hiura et al. 1999; Kumagai
et al. 1997), and mutagenicity (DeMarini et al.
2004). A study of Listeria monocytogenes infec-
tion in the rat lung showed that DEPs sup-
press host clearance of Listeria through
decreased ROS and NO generation, phagocy-
tosis, and proinﬂammatory cytokine secretion
by Listeria-activated AMs (Yang et al. 2001;
Yin et al. 2002, 2003). DEPEs also induce
ROS generation through the cytochrome
P450 (CYP) monooxygenase system during
the catalytic cycle (Puntarulo and Cederbaum
1998). CYP1A1, which is inducible by
polycyclic aromatic hydrocarbons (PAHs)
(Kuljukka-Rabb et al. 2001) present in DEPs,
is known to induce oxidative stress and trans-
forms procarcinogenic compounds to car-
cinogenic metabolites (Bondy and Naderi
1994). The normal rat lung contains
CYP2B1 as the constitutive CYP isoform but
has very low levels of CYP1A1 (Voigt et al.
1990). Exposure of rats to DEPs results in a
signiﬁcant and transient increase in CYP1A1
but a sustained decrease in CYP2B1, along
with a suppression of the phase II enzymes,
glutathione S-transferase (GST), and catalase
(Rengasamy et al. 2003). Thus, DEP expo-
sure can alter not only oxidant generation but
also the metabolic activity–dependent muta-
gen activation in the lung (Zhao et al. 2004).
Our studies have shown that DEPs
induce iNOS and NO production by naive
AMs but inhibit both lipopolysaccharide
(LPS)-mediated and Listeria-mediated NO
production by rat AM (Yang et al. 1999,
2001), suggesting that DEPs may affect NO
production directly as well as involving other
mediators. It is well known (White and
Marletta 1992) that iNOS is a hemoprotein
that contains both a reductase and a heme
domain on the same polypeptide. The ﬂavin-
containing reductase domain is similar in
function to NADPH CYP reductase and is
capable of producing superoxide with com-
pounds such as quinones and nitroarenes
found in DEPs (Kumagai et al. 1998). A con-
current production of NO and superoxide by
iNOS may lead to the formation of peroxy-
nitrite, a reactive intermediate that is known
to cause protein damage through nitration of
tyrosine, tryptophan, or cysteine residues (Lin
et al. 2003). The fact that DEPs contain
compounds that produce superoxide through
interaction with the reductase domain of
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Diesel exhaust particles (DEPs) have been shown to activate oxidant generation by alveolar
macrophages (AMs), alter xenobiotic metabolic pathways, and modify the balance of pro-
antiinﬂammatory cytokines. In this study we investigated the role of nitric oxide (NO) in DEP-
mediated and DEP organic extract (DEPE)-mediated inflammatory responses and evaluated the
interaction of inducible NO synthase (iNOS) and cytochrome P450 1A1 (CYP1A1). Male
Sprague-Dawley rats were intratracheally (IT) instilled with saline, DEPs (35 mg/kg), or DEPEs
(equivalent to 35 mg DEP/kg), with or without further treatment with an iNOS inhibitor,
aminoguanidine (AG; 100 mg/kg), by intraperitoneal injection 30 min before and 3, 6, and 9 hr
after IT exposure. At 1 day postexposure, both DEPs and DEPEs induced iNOS expression and
NO production by AMs. AG significantly lowered DEP- and DEPE-induced iNOS activity but
not the protein level while attenuating DEPE- but not DEP-mediated pulmonary inﬂammation,
airway damage, and oxidant generation by AMs. DEP or DEPE exposure resulted in elevated
secretion of both interleukin (IL)-12 and IL-10 by AMs. AG significantly reduced DEP- and
DEPE-activated AMs in IL-12 production. In comparison, AG inhibited IL-10 production by
DEPE-exposed AMs but markedly increased its production by DEP-exposed AMs, suggesting that
NO differentially regulates the pro- and antiinflammatory cytokine balance in the lung. Both
DEPs and DEPEs induced CYP1A1 expression. AG strongly inhibited CYP1A1 activity and lung
S9 activity-dependent 2-aminoanthracene mutagenicity. These studies show that NO plays a
major role in DEPE-induced lung inflammation and CYP-dependent mutagen activation but a
lesser role in particulate-induced inflammatory damage. Key words: cytochrome P450 1A1,
cytokine production, diesel exhaust particles, inflammation, mutagenicity, nitric oxide. Environ
Health Perspect 114:1253–1258 (2006). doi:10.1289/ehp.9063 available via http://dx.doi.org/
[Online 30 May 2006]iNOS suggests that the production of NO
and peroxynitrite may play a role in DEP-
mediated pulmonary toxicity, including
weakening of the lung’s host defense against
bacterial infection.
Studies have suggested that NO may
down-regulate certain CYP enzymes through
interaction with the heme site. The inhibition
of phenobarbital-induced CYP2B1/2 activity
by LPS, for example, was attributed to NO-
or peroxynitrite-mediated protein nitration
(Khatsenko et al. 1997) at the Tyr190 residue
(Lin et al. 2003). However, the effect of NO
on the PAH-induced CYP1A1 activity, which
is one of the more active CYP isoforms in
superoxide generation (Puntarulo and
Cederbaum 1998), has not been demon-
strated. We hypothesized that NO plays an
important role in modulating pulmonary
inflammatory responses through an oxidant-
mediated pathway and may also mediate
CYP1A1 activity. In the present study,
through in vivo inhibition of iNOS activity
using aminoguanidine (AG), a selective
inhibitor for iNOS (Misko et al. 1993), we
examined a possible cooperative action
between iNOS and CYP1A1 in mediating
DEP-induced pulmonary inflammatory and
mutagenic responses and investigated the
roles of DEPEs and the particulate in mediat-
ing DEP-induced pulmonary toxicity.
Materials and Methods
Animal treatment. DEPs and DEPEs
(National Institute of Standards and
Technology, Gaithersburg, MD; Standard
Reference Materials 2975 and 1975, respec-
tively) were autoclaved and mixed with pyro-
gen-free sterile saline. The suspensions were
sonicated for 5 min using an ultrasonic
processor with a micro tip (Branson Soniﬁer
450; Branson Ultrasonics, Danbury, CT)
before intratracheal (IT) instillation. We pur-
chased specific pathogen-free male Sprague-
Dawley (Hla:SD-CVF) rats (~ 200 g) from
Hilltop Laboratories (Scottdale, PA). Rats
were kept in cages individually ventilated with
HEPA-filtered air, housed in a facility
approved by the Association for Assessment
and Accreditation of Laboratory Animal Care
and provided food and water ad libitum. The
animals were humanely treated and with
regard for alleviation of suffering. Animals
were used after a 1 week acclimatization
period. Rats were anesthetized with sodium
methohexital (35 mg/kg intraperitoneally) and
placed on an inclined restraint board. A
0.3-mL suspension of DEPs at a dose of
35 mg/kg body weight, or equivalent amount
of DEPEs contained in the DEP dose, or
saline (control) was intratracheally instilled.
We treated another group of rats with AG
(100 mg/kg) by intraperitoneal injection at
30 min before and 3, 6 and 9 hr after IT
instillation of DEPs, DEPEs, or saline. Rats
were sacriﬁced at 1 day postexposure.
Isolation of AMs and AM cultures.
Animals were anesthetized with sodium pen-
tobarbital (0.2 g/kg) and exsanguinated by
cutting the renal artery. We obtained AMs by
bronchoalveolar lavage with a Ca2+/Mg2+-free
phosphate-buffered medium (145 mM NaCl,
5 mM KCl, 1.9 mM NaH2PO4, 9.35 mM
Na2HPO4, and 5.5 mM glucose; pH 7.4) as
described previously (Yang et al. 2001). The
acellular supernate from the first lavage was
saved separately from subsequent lavages for
analysis of lactate dehydrogenase (LDH) activ-
ity and protein content. Cell pellets from each
animal were centrifuged, combined, washed,
and resuspended in a HEPES-buffered
medium (145 mM NaCl, 5 mM KCl, 10 mM
HEPES, 5.5 mM glucose, and 1.0 mM
CaCl2; pH 7.4). Cell counts and purity were
measured using an electronic cell counter
equipped with a cell sizing attachment
(Coulter model Multisizer II with a 256C
channelizer; Coulter Electronics, Hialeah, FL).
AM-enriched cells were obtained by
adherence of lavaged cells to the tissue culture
plate as described previously (Yang et al. 1999)
and cultured in fresh Eagle minimum essential
medium (BioWhittaker, Walkersville, MD)
for an additional 24 hr. AM-conditioned
media were collected and centrifuged, and the
supernates were saved in aliquots at –80°C for
further analysis of cytokines.
Determination of protein, LDH, and
chemiluminescence. We monitored the acellu-
lar LDH activity in bronchoalveolar fluid
(BALF) using Roche Diagnostic reagents and
procedures on an automated Cobas MIRA
PLUS analyzer (Roche Diagnostic Systems,
Indianapolis, IN). We measured the protein
content in the acellular BALF using a biuret
reagent with Sigma diagnostic reagents and
procedures (Sigma Chemical Co., St. Louis,
MO) and following the manufacturer’s proto-
col. Chemiluminescence (CL) generated by
AMs was determined using an automated lumi-
nometer (Berthold Autolumat LB 953; Wallac
Inc., Gaithersburg, MD) as described by Yang
et al. (2001). Brieﬂy, CL generated by AMs was
measured before and after stimulation with
zymosan (2 mg/mL ﬁnal concentration; Sigma
Chemical Co.), a particle stimulant that acti-
vates macrophages. Zymosan-stimulated CL
was calculated as the total counts in the pres-
ence of stimulant minus the corresponding
basal counts. 
Cytokine assays and the determination of
nitrite (NO2
–) and peroxynitrite. Interleukin
(IL)-12p40) and IL-10 in AM-conditioned
media were determined using ELISAs
(Biosource International Inc., Camarillo, CA)
according to the manufacturer’s protocol. NO
production was determined in AM-conditioned
medium using the Greiss reaction (Green et al.
1982). We measured peroxynitrite by monitor-
ing the formation of rhodamine 123 ﬂuoromet-
rically (500 nm excitation, 536 nm emission)
according to the rhodamine standard curve
(Kooy et al. 1994), using a PerkinElmer LS50
Luminescence Spectrometer (PerkinElmer,
Inc., Norwalk, CT).
Preparation of lung S9 and microsomal
fractions. Rats from various exposure groups
were anesthetized with pentobarbital sodium
(0.2 g/kg), and the heart and lungs were
removed. The lung S9 was obtained by cen-
trifugation of tissue homogenate at 9,000 × g
for 20 min at 4°C; the supernatant was saved as
lung S9 fraction as described previously (Zhao
et al. 2004) and stored at –80°C until use. The
microsomal (pellet) and cytosolic (supernatant)
fractions of the tissue homogenate were
obtained by differential centrifugation. We
then resuspended the microsomal pellet in
incubation medium at a tissue concentration of
1 g/mL and determined protein concentrations
of both fractions using a bicinchoninic acid
protein assay kit (Pierce, Rockford, IL).
Enzyme level and activity assay. At 1 day
postexposure, CYP1A1 and CYP2B1 were
fractionated by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis and transferred
to a nitrocellulose membrane for Western blot
analysis, using rabbit polyclonal antibodies
speciﬁc for CYP1A1 or CYP2B1, to measure
CYP1A1 and CYP2B1 levels in lung micro-
somes, as described previously (Rengasamy
et al. 2003). We measured the activities of
7-ethoxyresoruﬁn O-dealkylase (EROD) and
7-pentoxyresoruﬁn O-dealkylase (PROD) by
monitoring the production of resoruﬁn ﬂuo-
rometrically according to the method of Burke
et al. (1994) and using a luminescence
spectrometer (model LS50; PerkinElmer,
Inc.). We quantiﬁed the resoruﬁn formation
using a resoruﬁn standard curve and measured
the activity of GST by monitoring GST-
dependent conjugation of glutathione and
1-chloro-2,4-dinitrobenzene spectrophoto-
metrically using a model UV-2401 PC spec-
trophotometer (Shimadzu, Columbia, MD) at
340 nm (Habig et al. 1974). We measured
the quinone reductase (QR) activity using a
spectrophotometric assay in which we
monitored the rate of reduction of 2,6-
dichlorophenolindophenol at 590 nm with
the spectrophotometer (Rengasamy et al.
2003). The catalase activity was determined
using a catalase assay kit (Cayman Chemical
Co., Ann Arbor, MI) according to manufac-
turer’s protocol.
Salmonella typhimurium/microsomal
assay. We used S. typhimurium strain
YG1024, which detects frameshift mutagens,
for the Ames test and 2-aminoanthracene
(2-AA; 0.015 µg/plate), a mutagen that
requires metabolic activation, as the substrate.
We performed the Salmonella mutation test
Zhao et al.
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described in a previous study (Zhao et al.
2004). We performed all assays in duplicate
plates and repeated each experiment at least
3 times with different animals. Spontaneous
revertants were subtracted from the number
of revertants obtained for each assay.
Statistical analysis. Data are presented as
means ± SEs. Comparisons were made using
one-way analysis of variance with means test-
ing by Dunnett’s test. p-Values < 0.05 were
considered to be signiﬁcant.
Results
Differentiation of DEP- or DEPE-induced
iNOS expression and activity in AMs. Western
blot analysis shows that both DEP and DEPE
induced iNOS expression in AMs, with levels
12- and 6-fold above the control, respectively
(data not shown). This induction of iNOS
expression correlated with signiﬁcant increases
in cellular production of NO (8-fold for DEPs
and 4-fold for DEPEs) and peroxynitrite
(10-fold for DEPs and 3-fold for DEPEs)
(Figure 1A,B). AG did not affect DEP- or
DEPE-induced iNOS expression in AMs but
significantly decreased DEP- or DEPE-
induced NO production (Figure 1A). In con-
trast, AG signiﬁcantly attenuated peroxynitrite
production after DEPE exposure but not after
exposure to DEPs (Figure 1B). In addition
Figure 1C shows that the overall production of
oxidants by DEP-exposed AMs in response to
zymosan challenge was much greater than that
of DEPE-exposed AMs, and that AG blocked
oxidant generation resulting from DEPEs but
not from DEPs. These results suggest that
DEPs may induce oxidant generation through
iNOS as well as particle-induced respiratory
burst activity, but oxidants generated by
DEPE-exposed AMs occur mainly through the
intracellular iNOS pathway.
Role of iNOS in DEP- and DEPE-
induced lung injury and AM production of
cytokines. Both DEP and DEPE exposures
caused a significant neutrophil recruitment
(Figure 2A), cytotoxicity measured as increased
LDH activity in the lavage ﬂuid (Figure 2B),
and damage to the alveolar air–blood barrier as
indicated by increased protein content in the
lavage fluid (Figure 2C). Inhibition of NO
production by AG attenuated the effect caused
by DEPEs but not by DEPs. Together,
Figures 1 and 2 suggest that DEP-induced
acute lung injury involves particle-induced res-
piratory bursts, whereas DEPEs induce cyto-
toxicity through an intracellular mechanism
that more strongly involves the expression and
activity of iNOS. Thus, AG was not effective
on particle-induced oxidant generation.
AMs from both DEP- and DEPE-exposed
rats secreted elevated levels of IL-12 and IL-10
compared with those of saline control rats
(Figure 3). IL-12 is a proinflammatory
cytokine known to elicit a T-lymphocyte–
mediated immune response against bacterial
infection (Hsieh et al. 1993), whereas IL-10 is
an antiinﬂammatory cytokine known to pro-
long the survival of intracellular pathogens in
AM (Redpath et al. 2001). AM production of
IL-12 and IL-10 in response to DEPEs was
markedly inhibited by the AG treatment, sug-
gesting that the production of both cytokines
is mediated through an NO-sensitive pathway.
In comparison, AG treatment significantly
decreased DEP-induced IL-12 production but
further enhanced IL-10 release from AMs.
This suggests that for DEP exposure, the role
of iNOS in the production of IL-12 and
IL-10 differs markedly.
Effect of iNOS activity on DEP- or DEPE-
induced expression and activity of CYP
enzymes. The induction of CYP1A1 expression
and activity in lung microsomes by DEPs and
DEPEs at 1 day postexposure is shown in
Figure 4. The AG treatment did not alter
CYP1A1 protein levels in either DEP- or
DEPE-exposed lung microsomes (Figure 4A)
but markedly decreased CYP1A1 activity
(Figure 4B). This suggests that the production
of NO may be required for CYP1A1 activity.
The results also show that exposure to DEPs
but not to DEPEs significantly reduced
CYP2B1 protein (Figure 4C) and PROD
activity (Figure 4D) in the rat lung, and AG
did not affect the expression or activity of
Role of nitric oxide in DEP-mediated lung toxicity
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Figure 1. Effects of AG treatment on DEP- and DEPE-induced oxidant generation at 1 day postexposure:
nitrite (A), peroxynitrite (B), and CL (C) production by AMs. Sa, saline. Results are presented as mean ± SE
from at least six different animals. 
*Signiﬁcantly different from control group, p < 0.05. **Signiﬁcantly different from the non-AG-treated group, p < 0.05.
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Figure 2. Role of NO in DEP- and DEPE-induced acute pulmonary inﬂammation, cellular toxicity, and lung
injury. The ﬁrst acellular lavage ﬂuid of the bronchoalveolar lavage was used to assay for inﬂammatory or
damage parameters. Sa, saline. Inﬂammation was determined by polymorphonuclear cell (PMN) inﬁltra-
tion (A), cytotoxicity was determined by monitoring LDH activity (B), and air–blood barrier damage was
monitored as protein content (C) in the lavage ﬂuid (n = 6–8). 
*Signiﬁcantly different from control group, p < 0.05. **Signiﬁcantly different from the non-AG-treated group, p < 0.05.
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Figure 3. Role of NO in DEP- and DEPE-mediated pro- and antiinflammatory cytokine production by AM.
Sa, saline. AM cells were isolated from different exposure groups with or without AG treatment. IL-12 (A)
and IL-10 (B) production in the supernatant of the AM culture medium, at 37°C for 24 hr, was assayed
using ELISA kits (n = 6–8). 
*Signiﬁcantly different from control group, p < 0.05. **Signiﬁcantly different from the non-AG-treated group, p < 0.05.CYP2B1 in either exposure system. DEPE
exposure had no effect on cytosolic phase II
enzymes (Table 1). However, DEP exposure
reduced the activities of cytosolic GST and
catalase, but not that of QR, and these DEP
effects were not influenced by AG. These
results further reveal a divergent effect of the
particulate versus organic components of diesel
exhaust, in that DEPEs induce CYP1A1,
whereas the particulate reduces CYP2B1 and
phase II metabolic enzymes. Figure 5 shows a
positive involvement of CYP1A1 in and a clear
effect of NO on the lung S9-dependent meta-
bolic activation of 2-AA mutagenicity. AG,
which attenuated CYP1A1 activity, caused a
significant and consistent lowering of 2-AA
mutagenic activation, suggesting that the pro-
duction of NO is crucial for the activation of
CYP1A1 activity and influences metabolic
activation of mutagens.
Discussion
DEPs alter both the acute and chronic
immune/inﬂammatory responses and modify
the outcome of such disease states as respira-
tory infection (Yang et al. 2001; Yin et al.
2002, 2003, 2004), allergic asthma (Nel et al.
2001), and lung cancer (Iwai et al. 2000). Our
objective in the present study was to investigate
the role of NO, induced by DEPs or DEPEs,
in mediating the particle-induced and/or
organic component–induced lung damage,
cytokine production by AMs, the alteration of
pulmonary xenobiotic metabolic pathways,
and metabolic activity–mediated mutagenic
activity. NO, a relatively stable uncharged radi-
cal that readily crosses lipid membranes, is a
good inter- and intracellular trafﬁcker in medi-
ating many cellular responses (Crow 1997).
Our studies show that with DEPE exposure, in
the absence of particle core, NO is directly
linked to lung inflammation and injury
because inhibition of iNOS activity by AG
abolished these adverse responses. DEP-
induced inflammatory responses, however,
were not significantly affected by AG treat-
ment, which suggests that particulate-induced
oxidant generation through the respiratory
burst is responsible for lung injury. These
results establish that both the particle core and
DEPEs contributed to DEP-induced oxidative
lung damage.
We have previously shown that exposure
of rats to DEPs before Listeria infection signif-
icantly reduced Listeria-stimulated NO pro-
duction by AMs, resulting in a slower
intrapulmonary Listeria clearance (Yang et al.
2001). In the present study we show that both
DEPs and DEPEs induce AMs in the produc-
tion of the proinﬂammatory cytokine IL-12.
This elevated IL-12 production is signiﬁcantly
diminished when rats were treated with AG,
suggesting that NO is a key mediator that ini-
tiates IL-12 production, which may lead to
IL-12-dependent T-lymphocyte–mediated
immune responses. Conversely, both DEP
and DEPE exposure  caused elevated IL-10
production. The AG treatment, however,
inhibited IL-10 release from DEPE-exposed
AMs but enhanced IL-10 production from
DEP-exposed AMs, suggesting that NO
down-regulates IL-10 secretion in particle-
exposed rats. This is consistent with our previ-
ous studies in which DEPs suppressed the
immunity against Listeria by down-regulating
IL-12 and up-regulating IL-10 production by
Listeria-infected AM (Yin et al. 2004). These
ﬁndings show that iNOS modulates the bal-
ance of AM-derived inﬂammatory mediators
for the host defense against bacterial infection
in DEP- or DEPE-exposed lung.
In the present study we show that the
induction of CYP1A1 by exposure to DEPs or
DEPEs was accompanied by an induction of
iNOS and that inhibition of iNOS activity by
AG nearly abolished CYP1A1 activity as
demonstrated by EROD. In comparison, the
constitutive CYP2B1 and cytosolic GST and
Zhao et al.
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Figure 4. Effects of AG treatment on CYP1A1 and CYP2B1 after DEP or DEPE exposure. At 1 day postexposure,
the intensities of CYP1A1 (A) and CYP2B1 (C) protein levels were quantiﬁed by densitometry and compared
with the saline (Sa) control and are presented here as percentage of control. The activities of CYP1A1 and
CYP2B1 were determined by monitoring EROD (B) and PROD (D) activity, respectively, and are presented as
percentage of control. The control saline value for CYP1A1 was 2.34 ± 0.68 pmol/min/mg protein and for
CYP2B1 was 5.24 ± 1.84 pmol/min/mg protein (n = 6–8). 
*Signiﬁcantly different from control group, p < 0.05. **Signiﬁcantly different from the non-AG-treated group, p < 0.05.
Table 1. Effects of AG treatment on DEP- or DEPE-exposed rat cytosolic phase II enzyme activities, GST,
catalase, and QR.
Percentage of saline control
GST Catalase QR
Treatment DEP DEPE DEP DEPE DEP DEPE
None 79 ± 3* 88 ± 7 73 ± 3* 135 ± 22 87 ± 3 96 ± 13
AG treatment 82 ± 5* 109 ± 7 67 ± 11* 199 ± 16** 95 ± 10 85 ± 6
Rats were  instilled IT with DEP or DEPE with or without AG treatment. The activities of GST, catalase, or QR were meas-
ured in the lung cytosol at 1 day postexposure as described in “Materials and Methods.” The activities of GST, catalase,
and QR are expressed as the percent change relative to saline control. The specific activities in the saline control for
GST, catalase, and QR were 204 ± 10, 80 ± 9 , and 659 ± 20 nmol/min/mg, respectively. 
*Signiﬁcantly different from the saline control, p< 0.05. **Signiﬁcantly different from the same exposure without AG treatment.
Figure 5. Effects of AG treatment on lung S9-
dependent 2-AA mutagenicity in S. typhimurium
strain YG1024. Sa, saline. Lung S9 were isolated at
1 day after saline, DEP, or DEPE exposure with or
without AG treatment. For each sample, Ames
assays were performed on duplicate plates. The
spontaneous revertants (29 ± 4/plate) were sub-
tracted from the number of revertants obtained
for each assay. Results are presented as mean ± SE
(n = 3). 
*Significantly different from control group, p < 0.05.
**Significantly different from the non-AG-treated group,
p < 0.05.
1,000
800
600
400
200
0
0
R
e
v
e
r
t
a
n
t
s
/
p
l
a
t
e
*,**
20 40 60 80 100 120 140 160 180 200 220
*
S9 protein (μg)/plate
Sa
Sa + AG
DEPE
DEPE + AG
DEP
DEP + AGRole of nitric oxide in DEP-mediated lung toxicity
Environmental Health Perspectives • VOLUME 114 | NUMBER 8 | August 2006 1257
catalases in the lung were reduced by DEPs
but not by DEPEs and were not affected by
AG treatment, suggesting that NO was not
significantly involved in particle exposure–
induced enzyme degradation. Studies of the
role of NO in regulation of CYP enzymes
have yielded contradicting results, with most
studies suggesting that NO or peroxynitrite
may down-regulate the CYP enzyme activity.
Lin et al. (2003) showed that peroxynitrite can
cause nitration of Tyr190 of CYP2B1 and
lead to its inactivation. Studies have also sug-
gested that NO, through LPS stimulation,
suppressed CYP1A activity in astrocytes
(Nicholson et al. 2004). In a Kupffer cell–
hepatocyte co-culture, however, LPS markedly
down-regulated hepatic phenobarbital-
induced CYP2B1 activity through induced
tumor necrosis factor-α released from Kupffer
cells but not linked to NO production by
either cell type (Milosevic et al. 1999). We
demonstrate in the present study that DEP- or
DEPE-stimulated NO production through
iNOS plays a key role in activating CYP1A1
activity, as treating rats with AG inhibited
iNOS activity and decreased CYP1A1 activity.
Of interest, ex vivo addition of AG to isolated
lung microsomes did not affect the EROD
assay (data not shown), suggesting that AG
does not directly interact with CYP1A1.
DEPEs are known to contain substrates for
NADPH CYP reductase that produce super-
oxide and DNA scission (Kumagai et al.
1997). Our results show that exposure to
DEPs or DEPEs can result in concurrent
release of NO and ROS such as superoxide
anion (Figure 1A,C) that lead to the produc-
tion of peroxynitrite (Figure 1B), which may
cause oxidative damage to proteins and DNA.
The ratio of ROS to NO with respect to DEP
exposure, as measured by CL, is greater than
that for DEPE exposure because AG inhib-
ited DEPE-induced but not DEP-induced
CL. This suggests that iNOS plays a major
role in the organic component–induced oxi-
dant generation, whereas the induction of
oxidant generation by DEPs may involve
other mechanism(s) such as particle-induced
macrophage respiratory bursts.
The potential carcinogenic effects of the
particulate and organic components of DEPs
remain unclear. There is a lack of correlation
between carcinogenesis and the organic com-
ponents of DEPs (Gallagher et al. 1994).
Other studies have suggested that DEP-
induced ROS generation may lead to DNA
damage and the initiation of lung carcinogene-
sis (Ichinose et al. 1997; Iwai et al. 2000). In
the present study we show that DEP exposure
results in signiﬁcant induction and/or inactiva-
tion of certain pulmonary phase I and phase II
metabolic enzymes. The dose-dependent 2-AA
activation by DEP- and DEPE-exposed S9 is
similar to that of the control; however, the
effect of DEP- or DEPE-exposed S9 on muta-
gen activation was significantly inhibited by
AG, which suggests a cooperative reaction of
iNOS and CYP1A1 activity. In addition, fol-
lowing phase I metabolism, xenobiotics are fur-
ther metabolized or detoxified by phase II
enzymes such as GST and QR, which have
been shown to modify carcinogen metabolism
and cancer susceptibility (Clapper 2000). Our
study shows that through oxidant generation,
DEPs can cause alteration of the metabolic
pathways in the lung, including NO-mediated
CYP1A1 activity and inactivation of CYP2B1
and cytosolic GST and catalase, and contribute
to lung mutagenicity.
In summary, this study shows that iNOS,
induced by DEPs and DEPEs, plays an
important role in mediating DEP-induced
pulmonary cellular responses. DEPE-induced
NO, in the absence of particle core, causes
pulmonary inflammation and lung damage
and mediates the release of both IL-12 and
IL-10 by AM. Conversely, NO is only par-
tially involved in DEP-induced inﬂammation,
which involves both the organic chemical
effect and particle core–induced macrophage
respiratory burst. NO is key in mediating the
balance of pro- and antiinflammatory
cytokines in the DEP-exposed lung. Enhanced
production of IL-10 may increase the suscepti-
bility of DEP-exposed lung to bacterial infec-
tion. Furthermore, NO was found necessary
for CYP1A1 activity in both DEP- and
DEPE-exposed lungs. Inhibition of NO by
AG resulted in a lowered capability of the lung
to activate metabolic-activity–dependent
mutagenic agents.
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